Search Results

Real‐world study of the concomitant use of biphasic insulin aspart 30/70 with GLP‐1 receptor agonist versus first‐generation basal insulin with GLP‐1 receptor agonist in type 2 diabetes.

• Authors : Davies, Melanie; Alibegovic, Amra Ciric; Anil, Gayathri

Subjects: GLUCAGON-like peptide-1 agonists; COMBINATION drug therapy; RISK assessmentENGLAND

• Source: Diabetic Medicine; May2024, Vol. 41 Issue 5, p1-11, 11p

Record details

Twice-daily insulin degludec/insulin aspart provides superior fasting plasma glucose control and a reduced rate of hypoglycaemia compared with biphasic insulin aspart 30 in insulin-naïve adults with Type 2 diabetes.

• Authors : Franek, E.; Haluzík, M.; Canecki Varžić, S.

Subjects: BLOOD sugar analysis; HYPOGLYCEMIA; TYPE 2 diabetes complications

• Source: Diabetic Medicine; Apr2016, Vol. 33 Issue 4, p497-505, 9p, 1 Diagram, 1 Chart, 3 Graphs

Record details

The optimal morning:evening ratio in total dose of twice-daily biphasic insulin analogue in poorly controlled Type 2 diabetes: a 24-week multi-centre prospective, randomized controlled, open-labelled clinical study.

• Authors : Jung, C. H.; Park, J.‐Y.; Cho, J. H.

Subjects: TYPE 2 diabetes treatment; HYPOGLYCEMIC agents; BLOOD sugar monitoring

• Source: Diabetic Medicine; Jan2014, Vol. 31 Issue 1, p68-75, 8p, 1 Diagram, 3 Charts, 2 Graphs

Record details

Does serum 1,5-anhydroglucitol establish a relationship between improvements in HbA1c and postprandial glucose excursions? Supportive evidence utilizing the differential effects between biphasic insulin aspart 30 and insulin glargine.

• Authors : Moses AC; Raskin P; Khutoryansky N

• Source: Diabetic Medicine; Feb2008, Vol. 25 Issue 2, p200-205, 6p

Record details

Does serum 1,5-anhydroglucitol establish a relationship between improvements in HbA1c and postprandial glucose excursions? Supportive evidence utilizing the differential effects between biphasic insulin aspart 30 and insulin glargine.

• Authors : Moses, A. C.; Raskin, P.; Khutoryansky, N.

Subjects: GLYCOSYLATED hemoglobin; GLUCOSE; INSULIN

• Source: Diabetic Medicine; Feb2008, Vol. 25 Issue 2, p200-205, 6p, 1 Chart, 5 Graphs

Record details

Pharmacokinetic profiles of biphasic insulin aspart 30/70 and 70/30 in patients with Type 1 diabetes: a randomized double-blinded crossover study.

• Authors : Chen J; Lauritzen T; Christiansen JJ

• Source: Diabetic Medicine; Mar2005, Vol. 22 Issue 3, p273-277, 5p

Record details

Reduced postprandial glycaemic excursion with biphasic insulin Aspart 30 injected immediately before a meal.

• Authors : Kapitza C (AUTHOR); Rave K (AUTHOR); Ostrowski K (AUTHOR)

• Source: Diabetic Medicine. May2004, Vol. 21 Issue 5, p500-501. 2p.

Record details